# Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

Source: https://onco.cc/trials/nct02584244/  
OnCo record `nct02584244` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of LUM015 in colorectal cancer, pancreatic ductal adenocarcinoma, oesophageal cancer and gastric & gastro-oesophageal junction cancer, run by Lumicell, Inc., now recruiting.

## Summary

Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers is a phase 1/2 interventional study registered as NCT02584244 by Lumicell, Inc., with 66 participants planned, started 2016-08-04 and due to reach its primary completion in 2026-12. Interventions recorded: LUM015 and LUM 2.6 Imaging Device.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT02584244
- Phase: 1/2
- Setting: Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- Sponsor: Lumicell, Inc.
- Enrolled: 66

## Sources

- ClinicalTrials.gov NCT02584244: https://clinicaltrials.gov/study/NCT02584244

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Gastric & gastro-oesophageal junction cancer](https://onco.cc/cancers/gastric/), [Oesophageal cancer](https://onco.cc/cancers/esophageal/), [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- companies: [Lumicell](https://onco.cc/companies/lumicell/)

---
JSON: https://onco.cc/api/v1/entities/nct02584244.json